The use of citric acid to prolong the in vivo gastro-retention of a floating dosage form in the fasted state
- PMID: 16338108
- DOI: 10.1016/j.ijpharm.2005.09.036
The use of citric acid to prolong the in vivo gastro-retention of a floating dosage form in the fasted state
Abstract
Gastro-retentive dosage forms have the potential to improve local therapy and decrease the variation in bioavailability that is observed with a number of commercially available immediate and modified release preparations. In this study, a dosage form has been developed, utilising freeze-dried calcium alginate beads, designed to float on the surface of the stomach contents thus prolonging the retention time. The aim of the study was to also assess the in vivo behaviour of the radio-labelled calcium alginate beads when they were administered under fasting conditions with either water or an aqueous solution of citric acid, a potential gut transit delaying substance. The study was performed in healthy male volunteers who swallowed the radio-labelled calcium alginate beads after a 10h overnight fast. Gamma scintigraphy was selected as the method to monitor the movement of the calcium alginate beads. The volunteers consumed no further food or drink until gastric emptying of the calcium alginate beads was complete. The results indicated that prolonged gastric retention was achieved when the dosage form was administered with the citric acid solution when compared to retention in the absence of citric acid. Citric acid, therefore, has the potential to delay the gastric emptying of the calcium alginate beads when administered to fasted volunteers.
Similar articles
-
Citric acid prolongs the gastro-retention of a floating dosage form and increases bioavailability of riboflavin in the fasted state.Int J Pharm. 2006 Feb 3;308(1-2):14-24. doi: 10.1016/j.ijpharm.2005.09.039. Epub 2005 Dec 15. Int J Pharm. 2006. PMID: 16343829 Clinical Trial.
-
Floating dosage forms to prolong gastro-retention--the characterisation of calcium alginate beads.Int J Pharm. 2008 Feb 28;350(1-2):301-11. doi: 10.1016/j.ijpharm.2007.09.009. Epub 2007 Sep 14. Int J Pharm. 2008. PMID: 17964096
-
Stomach-specific drug delivery of 5-fluorouracil using floating alginate beads.AAPS PharmSciTech. 2007 Jun 22;8(2):Article 48. doi: 10.1208/pt0802048. AAPS PharmSciTech. 2007. PMID: 17625805 Free PMC article.
-
Alginate drug delivery systems: application in context of pharmaceutical and biomedical research.Drug Dev Ind Pharm. 2014 Dec;40(12):1576-84. doi: 10.3109/03639045.2014.917657. Epub 2014 Aug 11. Drug Dev Ind Pharm. 2014. PMID: 25109399 Review.
-
Phase transition system: novel oral in-situ gel.Curr Drug Deliv. 2008 Oct;5(4):282-9. doi: 10.2174/156720108785914952. Curr Drug Deliv. 2008. PMID: 18855597 Review.
Cited by
-
Preparation and evaluation of berberine alginate beads for stomach-specific delivery.Molecules. 2011 Dec 14;16(12):10347-56. doi: 10.3390/molecules161210347. Molecules. 2011. PMID: 22169938 Free PMC article.
-
New Organic Salt from Levofloxacin-Citric Acid: What Is the Impact on the Stability and Antibiotic Potency?Molecules. 2022 Mar 27;27(7):2166. doi: 10.3390/molecules27072166. Molecules. 2022. PMID: 35408567 Free PMC article.
-
Optimization of a dual mechanism gastrofloatable and gastroadhesive delivery system for narrow absorption window drugs.AAPS PharmSciTech. 2012 Mar;13(1):1-15. doi: 10.1208/s12249-011-9711-1. Epub 2011 Nov 3. AAPS PharmSciTech. 2012. PMID: 22048877 Free PMC article.
-
Influence of different types of low substituted hydroxypropyl cellulose on tableting, disintegration, and floating behaviour of floating drug delivery systems.Saudi Pharm J. 2015 Nov;23(6):658-66. doi: 10.1016/j.jsps.2014.09.001. Epub 2014 Oct 7. Saudi Pharm J. 2015. PMID: 26702261 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources